Advertisement
Screener

BIO-RAD LABORATORIES, INC. (BIO.B) Revenue from Contract with Customer, Including Assessed Tax

2.0 / 5 stars · 47/120 Roast Me

BIO-RAD LABORATORIES, INC. Revenue from Contract with Customer, Including Assessed Tax

BIO-RAD LABORATORIES, INC. (BIO.B) reported Revenue from Contract with Customer, Including Assessed Tax of $2.58 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Income Statement › Revenue

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-02-13

  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-12-31 was $667.50M, a 2.01% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-09-30 was $649.70M, a 2.78% increase year-over-year.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-06-30 was $638.50M, a 6.25% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2024-03-31 was $610.80M, a 9.75% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $2.58B, a 0.65% increase from fiscal 2024.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $2.57B, a 3.92% decline from fiscal 2023.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $2.67B, a 4.67% decline from fiscal 2022.
  • BIO-RAD LABORATORIES, INC. revenue from contract with customer, including assessed tax for fiscal 2022 was $2.80B, a 4.12% decline from fiscal 2021.
Period endRevenue from Contract with Customer, Including Assessed Tax 3 monthRevenue from Contract with Customer, Including Assessed Tax 6 monthRevenue from Contract with Customer, Including Assessed Tax 9 monthRevenue from Contract with Customer, Including Assessed Tax 12 monthRevenue from Contract with Customer, Including Assessed Tax 12 month as first filed
2025-12-31$2.58B
10-K · filed 2026-02-13
2024-12-31$667.50M
10-K · filed 2025-02-14
$1.32B
derived: sum of 2 quarters · filed 2025-02-14
$1.96B
derived: sum of 3 quarters · filed 2025-02-14
$2.57B
10-K · filed 2026-02-13
2024-09-30$649.70M
10-K · filed 2025-02-14
$1.29B
derived: sum of 2 quarters · filed 2025-02-14
$1.90B
derived: sum of 3 quarters · filed 2025-02-14
$2.58B
derived: sum of 4 quarters · filed 2025-02-14
2024-06-30$638.50M
10-K · filed 2025-02-14
$1.25B
derived: sum of 2 quarters · filed 2025-02-14
$1.93B
derived: sum of 3 quarters · filed 2025-02-14
$2.56B
derived: sum of 4 quarters · filed 2025-02-14
2024-03-31$610.80M
10-K · filed 2025-02-14
$1.29B
derived: sum of 2 quarters · filed 2025-02-14
$1.92B
derived: sum of 3 quarters · filed 2025-02-14
$2.61B
derived: sum of 4 quarters · filed 2025-02-14
2023-12-31$681.20M
10-K · filed 2025-02-14
$1.31B
derived: sum of 2 quarters · filed 2025-02-14
$1.99B
derived: sum of 3 quarters · filed 2025-02-14
$2.67B
10-K · filed 2026-02-13
$2.67B
10-K · filed 2024-02-16
2023-09-30$632.10M
10-K · filed 2025-02-14
$1.31B
derived: sum of 2 quarters · filed 2025-02-14
$1.99B
derived: sum of 3 quarters · filed 2025-02-14
$2.72B
derived: sum of 4 quarters · filed 2025-02-14
2023-06-30$681.10M
10-K · filed 2025-02-14
$1.36B
derived: sum of 2 quarters · filed 2025-02-14
$2.09B
derived: sum of 3 quarters · filed 2025-02-14
$2.77B
derived: sum of 4 quarters · filed 2025-02-14
2023-03-31$676.80M
10-K · filed 2025-02-14
$1.41B
derived: sum of 2 quarters · filed 2025-02-14
$2.09B
derived: sum of 3 quarters · filed 2025-02-14
$2.78B
derived: sum of 4 quarters · filed 2025-02-14
2022-12-31$730.30M
10-K · filed 2024-02-16
$1.41B
derived: sum of 2 quarters · filed 2024-02-16
$2.10B
derived: sum of 3 quarters · filed 2024-02-16
$2.80B
10-K · filed 2025-02-14
$2.80B
10-K · filed 2023-02-17
2022-09-30$680.80M
10-K · filed 2024-02-16
$1.37B
derived: sum of 2 quarters · filed 2024-02-16
$2.07B
derived: sum of 3 quarters · filed 2024-02-16
$2.80B
derived: sum of 4 quarters · filed 2024-02-16
2022-06-30$691.10M
10-K · filed 2024-02-16
$1.39B
derived: sum of 2 quarters · filed 2024-02-16
$2.12B
derived: sum of 3 quarters · filed 2024-02-16
$2.87B
derived: sum of 4 quarters · filed 2024-02-16
2022-03-31$700.10M
10-K · filed 2024-02-16
$1.43B
derived: sum of 2 quarters · filed 2024-02-16
$2.18B
derived: sum of 3 quarters · filed 2024-02-16
$2.90B
derived: sum of 4 quarters · filed 2024-02-16
2021-12-31$732.80M
10-K · filed 2023-02-17
$1.48B
derived: sum of 2 quarters · filed 2023-02-17
$2.20B
derived: sum of 3 quarters · filed 2023-02-17
$2.92B
10-K · filed 2024-02-16
2021-09-30$747.00M
10-K · filed 2023-02-17
$1.46B
derived: sum of 2 quarters · filed 2023-02-17
$2.19B
derived: sum of 3 quarters · filed 2023-02-17
$2.98B
derived: sum of 4 quarters · filed 2023-02-17
2021-06-30$715.90M
10-K · filed 2023-02-17
$1.44B
derived: sum of 2 quarters · filed 2023-02-17
$2.23B
derived: sum of 3 quarters · filed 2023-02-17
$2.88B
derived: sum of 4 quarters · filed 2023-02-17
2021-03-31$726.80M
10-K · filed 2023-02-17
$1.52B
derived: sum of 2 quarters · filed 2023-02-17
$2.16B
derived: sum of 3 quarters · filed 2023-02-17
$2.70B
derived: sum of 4 quarters · filed 2023-02-17
2020-12-31$789.80M
10-K · filed 2022-02-11
$1.44B
derived: sum of 2 quarters · filed 2022-02-11
$1.97B
derived: sum of 3 quarters · filed 2022-02-11
$2.55B
10-K · filed 2023-02-17
2020-09-30$647.30M
10-K · filed 2022-02-11
$1.18B
derived: sum of 2 quarters · filed 2022-02-11
$1.76B
derived: sum of 3 quarters · filed 2022-02-11
$2.38B
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$536.90M
10-K · filed 2022-02-11
$1.11B
derived: sum of 2 quarters · filed 2022-02-11
$1.73B
derived: sum of 3 quarters · filed 2022-02-11
$2.29B
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$571.60M
10-K · filed 2022-02-11
$1.20B
derived: sum of 2 quarters · filed 2022-02-11
$1.76B
derived: sum of 3 quarters · filed 2022-02-11
$2.33B
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31$624.50M
10-K · filed 2021-02-16
$1.19B
derived: sum of 2 quarters · filed 2021-02-16
$1.76B
derived: sum of 3 quarters · filed 2021-02-16
$2.31B
10-K · filed 2022-02-11
2019-09-30$560.60M
10-K · filed 2021-02-16
$1.13B
derived: sum of 2 quarters · filed 2021-02-16
$1.69B
derived: sum of 3 quarters · filed 2021-02-16
$2.30B
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$572.60M
10-K · filed 2021-02-16
$1.13B
derived: sum of 2 quarters · filed 2021-02-16
$1.74B
derived: sum of 3 quarters · filed 2021-02-16
$2.29B
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$554.00M
10-K · filed 2021-02-16
$1.17B
derived: sum of 2 quarters · filed 2021-02-16
$1.72B
derived: sum of 3 quarters · filed 2021-02-16
$2.29B
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31$616.90M
10-K · filed 2020-03-02
$1.16B
derived: sum of 2 quarters · filed 2020-03-02
$1.74B
derived: sum of 3 quarters · filed 2020-03-02
$2.29B
10-K · filed 2021-02-16
2018-09-30$545.10M
10-K · filed 2020-03-02
$1.12B
derived: sum of 2 quarters · filed 2020-03-02
$1.67B
derived: sum of 3 quarters · filed 2020-03-02
$2.29B
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$575.90M
10-K · filed 2020-03-02
$1.13B
derived: sum of 2 quarters · filed 2020-03-02
$1.75B
derived: sum of 3 quarters · filed 2020-03-02
$2.28B
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$551.50M
10-K · filed 2020-03-02
$1.17B
derived: sum of 2 quarters · filed 2020-03-02
$1.71B
derived: sum of 3 quarters · filed 2020-03-02
$2.21B
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$621.30M
10-K · filed 2019-04-01
$1.16B
derived: sum of 2 quarters · filed 2019-04-01
$1.66B
derived: sum of 3 quarters · filed 2019-04-01
$2.16B
10-K · filed 2020-03-02
2017-09-30$534.10M
10-K · filed 2019-04-01
$1.04B
derived: sum of 2 quarters · filed 2019-04-01
$1.54B
derived: sum of 3 quarters · filed 2019-04-01
2017-06-30$504.70M
10-K · filed 2019-04-01
$1.00B
derived: sum of 2 quarters · filed 2019-04-01
2017-03-31$500.10M
10-K · filed 2019-04-01
2016-12-31$2.07B
10-K · filed 2019-04-01